4BASEBIO PLC Logo

4BASEBIO PLC

Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.

4BB | IL

Overview

Corporate Details

ISIN(s):
GB00BMCLYF79
LEI:
213800E2DX9EAIUNCB30
Country:
United Kingdom
Address:
25 NORMAN WAY, CB24 5QE CAMBRIDGESHIRE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

4basebio PLC is a life sciences company specializing in the design, development, and GMP-compliant manufacturing of synthetic DNA for advanced therapy medicinal products (ATMPs). The company provides high-performance nucleic acid products, including its proprietary opDNA®, as a scalable and efficient alternative to traditional plasmid DNA. Its solutions are engineered to accelerate the development of next-generation therapeutics and vaccines, including gene therapies, cell therapies, and mRNA-based medicines. By supplying critical DNA templates, 4basebio enables pharmaceutical and biotechnology partners to streamline manufacturing workflows and advance their research and clinical programs more efficiently.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-10 12:30
Post-Annual General Meeting Information
4basebio Plc - Result of Extraordinary General Meeting
English 8.8 KB
2025-09-30 17:20
Director's Dealing
4basebio Plc - Director Dealing
English 33.3 KB
2025-09-29 08:00
Interim Report
4basebio Plc - Half-year Report
English 312.8 KB
2025-07-22 08:00
Share Issue/Capital Change
4basebio Plc - Employee Long Term Incentive Plan and Issue of Equity
English 11.8 KB
2025-07-08 11:30
Board/Management Information
4basebio Plc - Director Appointment, Board Change
English 18.6 KB
2025-07-03 08:00
Major Shareholding Notification
4basebio Plc - Holding(s) in Company
English 41.5 KB
2025-07-03 08:00
Major Shareholding Notification
4basebio Plc - Holding(s) in Company
English 42.6 KB
2025-07-02 08:00
Major Shareholding Notification
4basebio Plc - Holding(s) in Company
English 42.6 KB
2025-07-02 08:00
Major Shareholding Notification
4basebio Plc - Holding(s) in Company
English 41.5 KB
2025-06-27 19:05
Post-Annual General Meeting Information
4basebio Plc - Result of AGM
English 8.7 KB
2025-06-25 08:00
Share Issue/Capital Change
4basebio Plc - Exercise of Options
English 10.8 KB
2025-06-17 08:00
Major Shareholding Notification
4basebio Plc - Holding(s) in Company
English 42.2 KB
2025-06-17 08:00
Major Shareholding Notification
4basebio Plc - Holding(s) in Company
English 42.5 KB
2025-05-27 08:00
Report Publication Announcement
4basebio Plc - Final Results and Notice of AGM
English 296.1 KB
2025-03-25 11:15
Major Shareholding Notification
4basebio Plc - Holding(s) in Company
English 42.4 KB

Automate Your Workflow. Get a real-time feed of all 4BASEBIO PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for 4BASEBIO PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea 291650
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway AZT
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands 1AE
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden AROC
Ascelia Pharma Logo
Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.
Sweden ACE
Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.
Japan 4886
Astellas Pharma Inc. Logo
A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.
Japan 4503
Astena Holdings Co., Ltd. Logo
Develops and sells chemicals, pharma, and ingredients for food, cosmetic, and industrial use.
Japan 8095

Talk to a Data Expert

Have a question? We'll get back to you promptly.